System to analyze factors affecting human islet yield

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43DK070402-01A1
Agency Tracking Number: DK070402
Amount: $195,331.00
Phase: Phase I
Program: SBIR
Awards Year: 2006
Solicitation Year: 2006
Solicitation Topic Code: N/A
Solicitation Number: PHS2006-2
Small Business Information
1102 Stadium Drive, INDIANAPOLIS, IN, 46202
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 ROBERT MCCARTHY
 (317) 917-3457
 vitacyte@indy.rr.com
Business Contact
Phone: (317) 917-3457
Email: VITACYTE@INDY.RR.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The Edmonton Protocol is a breakthrough in the treatment of adult, type 1 diabetic patients and heralds a new era in transplantation medicine. Edmonton's success rate, as measured by insulin independence > 1 year post transplant, is comparable to whole organ pancreas transplantation. The major barrier for routine clinical adoption of the Protocol is the poor recovery of islets from human pancreata. Typically, 2 or more organs are usually required to recover a sufficient number of islets for successful transplantation. A combination of enzymatic & mechanical techniques are used to free islets from the pancreas. Improvements to the islet isolation procedure have been made incrementally since no laboratory has had the resources or expertise to critically evaluate the interaction of three factors that affect islet yield: histochemical composition of the organ, quality and composition of the tissue dissociation enzymes (TDEs), and the amount of endogenous pancreatic proteolytic enzymes generated during the tissue dissociation procedure. This grant focuses on evaluating the feasibility for developing a tissue test system (TTS) that will fill this gap. The TTS is similar to a biochemical enzyme assay: purified proteolytic enzymes are used to digest minced porcine pancreatic tissue (substrate) with free islet volume expressed as an islet equivalent number as the product of this interaction. We believe that the TTS will allow systematic evaluation of factors that affect islet yield and with this information we can rapidly assess modifications in the reagents and isolation process that can lead to improvements in the quality and yield of islets used in transplantation. The 3 goals of this grant will be to define the optimal experimental parameters for the TTS, compare the amount and quality of islets recovered from the TTS to those obtained from the established procedure, and develop a histochemical staining procedure to improve characterization of the tissue substrate. If successful, this project will be extended in a Phase II application to develop a human TTS. Development of a human TTS may be an innovative approach to improve knowledge of factors that affect islet yield. The ability to perform multiple analyses on tissue derived from an individual organ eliminates the problem of interpreting data between organs, enabling further research to develop improved TDE reagents and islet isolation procedures that will increase the recovery of islets from human pancreata.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government